Orbital Infiltration as the First Site of Relapse of Primary Testicular T-cell Lymphoma.
- Author:
Hyun Jung JUN
1
;
Won Seog KIM
;
Ji Hyun YANG
;
Seong Yoon YI
;
Young H KO
;
Jeeyun LEE
;
Chul Won JUNG
;
Se Woong KANG
;
Keunchil PARK
Author Information
1. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. wskimsmc@smc.samsung.co.kr
- Publication Type:Case Report
- Keywords:
Non-Hodgkin's lymphoma;
T cell lymphoma;
Testes;
Eye neoplasm
- MeSH:
Adult;
Central Nervous System;
Ciliary Body;
Diagnosis;
Drug Therapy;
Eye Neoplasms;
Humans;
Lymphoma;
Lymphoma, Non-Hodgkin;
Lymphoma, T-Cell*;
Lymphoma, T-Cell, Peripheral;
Male;
Orbit*;
Orchiectomy;
Radiotherapy;
Recurrence*;
Stem Cell Transplantation;
T-Lymphocytes*;
Testis
- From:Cancer Research and Treatment
2007;39(1):40-43
- CountryRepublic of Korea
- Language:English
-
Abstract:
A 43-year-old male presented with a painless left testicular mass. The pathologic diagnosis of the radical orchiectomy specimen was peripheral T-cell lymphoma, unspecified (PTCL-u). According to the Ann Arbor staging system, his initial stage was III because of the right nasopharyngeal involvement. After first-line chemotherapy with four courses of the CHOP regimen and this was followed by involved-field radiotherapy, he achieved complete remission. Two months later, disease recurred to the left ciliary body of the left eye without evidence of involvement at other sites. Although the patient received intensive chemotherapy with autologous hema-topoietic stem cell transplantation, he ultimately died of leptomeningeal seeding. Because both the central nervous system (CNS) and the orbit are sanctuary sites for chemotherapy, orbital infiltration of lymphoma should prompt physicians to evaluate involvement of the CNS and to consider performing prophylactic intrathecal chemotherapy as a treatment option.
